We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Jury in Elizabeth Holmes Trial Ends Fourth Day of Deliberations
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Technology > Jury in Elizabeth Holmes Trial Ends Fourth Day of Deliberations
Jury in Elizabeth Holmes Trial Ends Fourth Day of Deliberations
Technology

Jury in Elizabeth Holmes Trial Ends Fourth Day of Deliberations

Last updated: December 28, 2021 4:48 am
Editorial Board Published December 28, 2021
Share
SHARE
27holmes deliberations facebookJumbo

SAN JOSE, Calif. — Jurors ended a fourth day of deliberations without a verdict on Monday in the fraud trial of Elizabeth Holmes, the founder of the failed blood testing start-up Theranos.

Ms. Holmes, 37, faces 11 counts of wire fraud and conspiracy to commit wire fraud over charges that she lied about Theranos’s technology as she sought investments and business for her start-up. If convicted, she faces up to 20 years in prison for each count of wire fraud.

A jury of eight men and four women also deliberated last Monday, Tuesday and Thursday. They are scheduled to return to federal court in San Jose, Calif., at 8:30 a.m. Tuesday to resume deliberations.

On Thursday, they asked to hear recordings of a call Ms. Holmes had with investors, in which she allegedly made misleading claims about Theranos’s partnerships with pharmaceutical companies and the military.

The jurors’ deliberations follow a nearly four-month trial that is viewed as a referendum on the worst excesses of Silicon Valley’s start-up culture. Before Theranos collapsed, Ms. Holmes was a highly celebrated female founder. She dropped out of Stanford University at age 19 to focus on her company and spent the next decade raising nearly $1 billion from investors.

In 2015, Theranos began to unravel after a Wall Street Journal investigation revealed that the company had relied on commercially available machines to perform many of its blood tests, rather than its own supposedly revolutionary devices. Theranos shut down in 2018, the same year Ms. Holmes was indicted.

During the trial, federal prosecutors have tried to prove that Ms. Holmes intentionally deceived investors, patients and commercial partners by forging validation reports, faking demonstrations and misrepresenting Theranos to the media and the public.

​​“She chose fraud over business failure,” Jeffrey Schenk, an assistant U.S. attorney, said during the government’s closing argument.

Ms. Holmes, who took the stand for seven days in her own defense, has tried painting herself as a well-meaning entrepreneur who believed her own claims and was led astray by those around her.

“She believed she was building a technology that would change the world,” said Kevin Downey, a lawyer for Ms. Holmes.

You Might Also Like

AI denial is turning into an enterprise threat: Why dismissing “slop” obscures actual functionality positive factors

GAM takes purpose at “context rot”: A dual-agent reminiscence structure that outperforms long-context LLMs

The 'reality serum' for AI: OpenAI’s new technique for coaching fashions to admit their errors

Anthropic vs. OpenAI pink teaming strategies reveal completely different safety priorities for enterprise AI

Inside NetSuite’s subsequent act: Evan Goldberg on the way forward for AI-powered enterprise methods

TAGGED:Computers and the InternetEntrepreneurshipFrauds and SwindlingHolmes, Elizabeth (1984- )Silicon Valley (Calif)Start-upsTests (Medical)The Washington MailTheranos IncVenture Capital
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
College-Educated Workers Help Unionize Places Like Starbucks
Business

College-Educated Workers Help Unionize Places Like Starbucks

Editorial Board April 28, 2022
Sleepagotchi Lite launches on Sony’s Soneium blockchain through Line Mini app
A Gene Sequencing Pioneer Battles Over What It Can Buy
Alcohol use dysfunction harms the mind’s immune system earlier in ladies
Can vitamin D dietary supplements actually gradual ageing, as a latest research suggests?

You Might Also Like

Nvidia's new AI framework trains an 8B mannequin to handle instruments like a professional
Technology

Nvidia's new AI framework trains an 8B mannequin to handle instruments like a professional

December 4, 2025
Gong examine: Gross sales groups utilizing AI generate 77% extra income per rep
Technology

Gong examine: Gross sales groups utilizing AI generate 77% extra income per rep

December 4, 2025
AWS launches Kiro powers with Stripe, Figma, and Datadog integrations for AI-assisted coding
Technology

AWS launches Kiro powers with Stripe, Figma, and Datadog integrations for AI-assisted coding

December 4, 2025
Workspace Studio goals to unravel the true agent drawback: Getting staff to make use of them
Technology

Workspace Studio goals to unravel the true agent drawback: Getting staff to make use of them

December 4, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?